Pingfei Li
Impact in
- Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Automotive Engineering top 5%
- Additive Manufacturing and 3D Printing Technologies
Papers in
-
- Advanced Drug Delivery Systems 7
- Drug Solubulity and Delivery Systems 2
-
- Additive Manufacturing and 3D Printing Technologies 5
- Co-authors
- Weisan Pan (12 shared papers)Xinggang Yang (11 shared papers)Mengsuo Cui (6 shared papers)Xiang‐Ping Yang (10 shared papers)Shiming Zhang (4 shared papers)Haoyang Wen (4 shared papers)Zhengping Wei (9 shared papers)Yining Yang (3 shared papers)
- Journals
- AAPS PharmSciTech (4 papers)Journal of Drug Delivery Science and Technology (2 papers)Vaccine (2 papers)Scientific Reports (2 papers)Seminars in Immunopathology (1 paper)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Pingfei Li
32 papers receiving 640 citations
Peers
Comparison fields: 5 of 71
- Pharmaceutical Science 154
- Automotive Engineering 155
- Hepatology 36
- Biomaterials 44
- Drug Discovery 1
Countries citing papers authored by Pingfei Li
This map shows the geographic impact of Pingfei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pingfei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pingfei Li more than expected).
Fields of papers citing papers by Pingfei Li
This network shows the impact of papers produced by Pingfei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pingfei Li. The network helps show where Pingfei Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Pingfei Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 52 | |
| 2 | 2018 | 48 | |
| 3 | 2017 | 44 | |
| 4 | 2018 | 43 | |
| 5 | 2017 | 37 | |
| 6 | 2007 | 36 | |
| 7 | 2019 | 32 | |
| 8 | 2019 | 30 | |
| 9 | 2019 | 28 | |
| 10 | 2024 | 28 | |
| 11 | 2021 | 27 | |
| 12 | 2018 | 24 | |
| 13 | 2021 | 22 | |
| 14 | 2022 | 22 | |
| 15 | 2006 | 21 | |
| 16 | 2016 | 20 | |
| 17 | 2019 | 20 | |
| 18 | 2017 | 18 | |
| 19 | 2019 | 18 | |
| 20 | 2007 | 14 |
About Pingfei Li
Pingfei Li is a scholar working on Pharmaceutical Science, Automotive Engineering, Immunology, Hepatology and Food Science, having authored 32 papers that have together received 659 indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (7 papers), Additive Manufacturing and 3D Printing Technologies (5 papers), T-cell and B-cell Immunology (4 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Drug Solubulity and Delivery Systems (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Hepatitis C virus research (2 papers) and Sepsis Diagnosis and Treatment (2 papers). The work is most often cited by research in Pharmaceutical Science (154 citations), Automotive Engineering (155 citations), Hepatology (36 citations), Biomaterials (44 citations) and Drug Discovery (1 citation). Pingfei Li has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Weisan Pan, Xinggang Yang, Mengsuo Cui, Xiang‐Ping Yang, Shiming Zhang, Haoyang Wen, Zhengping Wei, Yining Yang, Shu Wang and Hao Pan. Their work appears in journals such as AAPS PharmSciTech, Journal of Drug Delivery Science and Technology, Vaccine, Scientific Reports and Seminars in Immunopathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.